Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs Vytora Health

boostAGErx
Graded #201

Lower grade

vs+6.200000000000003
Vytora Health
Graded #79

Higher grade

The verdict

Vytora Health takes it — 72.3/100 to 66.1/100.

Vytora Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +15
74
59
Dose & formulationVytora Health +21
64
85
Clinical oversightVytora Health +22
74
96
Labs & monitoringVytora Health +3
52
55
FulfillmentVytora Health +11
85
96
Contract termsboostAGErx +5
25
20
boostAGErx · left barVytora Health · right bar

The numbers

MetricboostAGErxVytora Health
WeighScore66.1/10072.3/100
GradeCC
Scorecard rank#201#79
Semaglutide$95/mo (billed every 28 days, compounded)$180/mo (all doses, compounded)
Tirzepatide$145/mo (billed every 28 days, compounded)$249/mo (all doses, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
boostAGErx

Graded #201 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
  • The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
  • Prices are rendered entirely in JavaScript; the page's HTML body is empty, so nothing is readable without running the bundle
  • Shipped compounded medication is non-refundable
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Vytora Health

Graded #79 · C

Strengths

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)

Where it loses points

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard